Real World Data of Daclatasvir and Asunaprevir Combination Therapy for HCV Genotype 1b Infection in Patients With Renal Dysfunction  Masatoshi Ishigami,

Slides:



Advertisements
Similar presentations
The Role of Psychosocial Care in Adapting to Health Care Reform
Advertisements

Abnormal Liver Tests and Fatty Liver on Ultrasound
Thrombocytopenia With Abnormal Liver Function Tests
Core I97L mutation in conjunction with P79Q is associated with persistent low HBV DNA and HBs antigen clearance in patients with chronic hepatitis B 
Incorrect Calculation and Inappropriate Interpretation: Accuracy of International Guidelines for Identifying Significant Fibrosis in e Antigen–Negative.
Noncardiac Chest Pain Clinical Gastroenterology and Hepatology
Relationship Between Transferrin-Iron Saturation, Alcohol Consumption, and the Incidence of Cirrhosis and Liver Cancer  George N. Ioannou, Noel S. Weiss,
Value of Spatiotemporal Representation of Manometric Data
Pichamol Jirapinyo, Christopher C. Thompson 
Real World Data of Daclatasvir and Asunaprevir Combination Therapy for HCV Genotype 1b Infection in Patients With Renal Dysfunction  Masatoshi Ishigami,
A Shocking Cystory Clinical Gastroenterology and Hepatology
David L. McCollum, J. Martin Rodriguez 
Colonic Amyloidosis Clinical Gastroenterology and Hepatology
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Staging Hepatocellular Carcinoma by a Novel Scoring System (BALAD Score) Based on Serum Markers  Hidenori Toyoda, Takashi Kumada, Yukio Osaki, Hiroko.
Amnon Sonnenberg, MD, MSc, Brent Y. Lee, MD 
Retroperitoneal Benign Schwannoma in the Suprapancreatic Area
Yoji Ishizu, MD, PhD, Masatoshi Ishigami, MD, PhD 
Talya Salz, Robert S. Sandler  Clinical Gastroenterology and Hepatology 
Endocuff to Improve Adenoma Detection: Supported by Low-Quality Evidence or Not Supported by High-Quality Evidence?  Yao Zhang, MD, Sheng-Bing Zhao, MD 
Herbs and Liver Injury: A Clinical Perspective
Nghia H. Nguyen, Vincent Nguyen, Huy N. Trinh, Brian Lin, Mindie H
Jessica L. Mellinger, Michael L. Volk 
Interpreting Hepatitis B Surface Antigen Levels: Useful Clinical Test or Just Another Confusing Assay?  Brian J. McMahon, MD, Brenna C. Simons, PhD  Clinical.
Endoscopic Therapy for Barrett's Esophagus
Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection  Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco.
Severe Constipation Clinical Gastroenterology and Hepatology
Abnormal Liver Tests and Fatty Liver on Ultrasound
Gastroenterology in a New Era of Accountability: Part 2
High Incidence of Colonic Perforation During Colonoscopy in Hemodialysis Patients With End-Stage Renal Disease  Norihiro Imai, Kinichi Takeda, Teiji Kuzuya,
William D. Leslie  Clinical Gastroenterology and Hepatology 
New Models of Gastroenterology Practice
Issue Highlights Clinical Gastroenterology and Hepatology
David H. Bruining, William J. Sandborn 
Brendan Campbell, Benny Liu, Taft Bhuket, Robert J. Wong 
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Patient-Reported Outcomes of Cirrhosis
A Young Woman With Gallstone Pancreatitis and Abnormal Liver Tests: When Is Endoscopic Retrograde Cholangiopancreatography Needed?  Andrew D. Rhim, Michael.
Issue Highlights Clinical Gastroenterology and Hepatology
Tamir Ben–Menachem, Jason A. Dominitz 
Lia C. Kaufman, Jana G. Hashash 
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
Alan Bonder, MD, Nezam H. Afdhal, MD 
Suna Yapali, MD, Anna S. Lok, MD, FRCP 
Hannah I. Awai, Kimberly P. Newton, Claude B
Issue Highlights Clinical Gastroenterology and Hepatology
Hepatic Cyst? Clinical Gastroenterology and Hepatology
Thrombocytopenia With Abnormal Liver Function Tests
Christos Konstantakis, Maria Karamesini, Christos Triantos 
Immune Dysfunction and Infections in Patients With Cirrhosis
Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication  Lauren A. Beste, George.
Hepatitis C Virus Infection, Age, and Hispanic Ethnicity Increase Mortality From Liver Cancer in the United States  Zobair M. Younossi, Maria Stepanova 
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Patrick Yachimski, William P. Puricelli, Norman S. Nishioka 
Failure to Renew Prescriptions for Gastroprotective Agents to Patients on Continuous Nonsteroidal Anti-inflammatory Drugs Increases Rate of Upper Gastrointestinal.
Coagulation in Liver Disease: A Guide for the Clinician
Issue Highlights Clinical Gastroenterology and Hepatology
Endoscopic Therapy of Jejunal Diphyllobothrium nihonkaiense Infection
Black and White Liver Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
Adverse Outcomes: Why Bad Things Happen to Good People
Medical Therapy for Refractory Pediatric Crohn’s Disease
Challenges of NIH Funding for Young Investigators: How the AGA Is Filling the Gap via the AGA Research Foundation  Timothy C. Wang, Rhonda F. Souza  Clinical.
Issue Highlights Clinical Gastroenterology and Hepatology
Rintaro Hashimoto, Akimichi Chonan 
The Role of Psychosocial Care in Adapting to Health Care Reform
Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction
Karanprit Singh, Prateek Chapalamadugu, Peter Malet 
Choosing Wisely and the Perceived Drivers of Endoscopy Use
Presentation transcript:

Real World Data of Daclatasvir and Asunaprevir Combination Therapy for HCV Genotype 1b Infection in Patients With Renal Dysfunction  Masatoshi Ishigami, Kazuhiko Hayashi, Takashi Honda, Teiji Kuzuya, Yoji Ishizu, Tetsuya Ishikawa, Isao Nakano, Fumihiro Urano, Takashi Kumada, Kentaro Yoshioka, Hidemi Goto, Yoshiki Hirooka  Clinical Gastroenterology and Hepatology  Volume 15, Issue 5, Pages 787-788 (May 2017) DOI: 10.1016/j.cgh.2016.12.009 Copyright © 2017 AGA Institute Terms and Conditions

Figure 1 Rate of liver injury during treatment in patients with or without renal dysfunction according to the grade of liver injury. Grade 0, <1.25 times upper limited of normal (ULN); grade 1, ≥1.25 to <2.5 times ULN; grade 2, ≥2.5 to <5 times ULN; grade 3, ≥5 to <10 times ULN; grade 4, ≥10 times ULN. Liver injury according to grade in patients with an eGFR of (A) ≥50 mL/min, (B) 30–49 mL/min, (C) <30 mL/min, and (D) <50 mL/min is shown. Statistical value (P < .001) is based on the comparison between patients with eGFR of ≥50 mL/min (A) and those with eGFR <50 mL/min (D). Clinical Gastroenterology and Hepatology 2017 15, 787-788DOI: (10.1016/j.cgh.2016.12.009) Copyright © 2017 AGA Institute Terms and Conditions